Strategic Partnerships SoftWave TRT has established international manufacturing ties (German-engineered) and a history of partnerships, including Cynosure for aesthetics and sexual health markets, plus a federal contract with the VA. Leverage these connections to target large healthcare networks, dermatology/aesthetics clinics, and government procurement channels with bundled shockwave therapy solutions.

Clinical Evidence Over 300 published studies supporting the technology and adoption by top medical research centers indicate strong clinical credibility. Use this as a value prop to win hospital RFPs, academic collaborations, and physician-led pilot programs focused on tissue healing, orthopedics, wound care, and urology.

Expansion Potential Recent activity includes regional presence in Farmington, NY and strategic advisory growth, suggesting momentum in market expansion. Target multi-site clinics and health systems looking to standardize non-invasive, drug-free therapies across departments and geographies.

Public Sector Access Awarded a Federal Supply Schedule Contract with the Department of Veterans Affairs highlights public-sector procurement potential. Develop campaigns toward federal and state-funded programs, veteran healthcare networks, and bulk purchasing opportunities for clinics serving large patient volumes.

Revenue Growth Signals Reported revenue in the range of $10M-$25M and a broad global footprint imply scalable demand for shockwave therapy. Position value-based offerings, training, and service packages to address high-use settings such as orthopedics, wound care, and aesthetics, while proposing upgrades or maintenance contracts to existing customers.